Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

ResMed Inc. Common Stock (NY:RMD)

212.91 +1.42 (+0.67%)
Official Closing Price Updated: 7:00 PM EDT, Apr 17, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about ResMed Inc. Common Stock

< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Late-Summer Steals: 7 Stocks to Buy Before Fall
With the summer season coming to an end and investors returning from vacation, it’s time to consider these stocks to buy now. 
Via InvestorPlace
3 Growth Stocks That Can Soar 50%, According to Wall Street
Are these stocks the slam-dunk buys analysts think they are? 
Via The Motley Fool
Stocks That Hit 52-Week Lows On Wednesday
  Wednesday's session saw 150 companies set new 52-week lows. 
Via Benzinga
The Latest Analyst Ratings for ResMed
Via Benzinga
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $8,000 Today
Via Benzinga
Earnings Scheduled For August 3, 2023
Companies Reporting Before The Bell • Cedar Fair (NYSE:FUN) is likely to report quarterly earnings at $1.10 per share on revenue of $512.74 million. 
Via Benzinga
ResMed's Earnings: A Preview
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 5 Years
Via Benzinga
Buy the Drop: 3 Stocks to Snag After This Month’s 20% Tumble
With plenty of companies having their share prices corrected in August, it's time to shop for bargain stocks to buy on the dip. 
Via InvestorPlace
5 Blue-Chip Stocks AI Thinks Will Double Your Money by 2027
Blue-chip stocks are traditionally market laggards, but the MarketMaster AI is flashing major "buy" signals in these 5 names right now. 
Via InvestorPlace
Topics Artificial Intelligence
Exposures Artificial Intelligence
2 Stocks That Could Grow Your Portfolio Over the Next Decade
These two promising stocks could help your portfolio grow steadily over the long term. 
Via The Motley Fool
ResMed's Q4 Results: Analysts Say Uncertain Market Dynamics Follow Amid Philips Re-Entry
ResMed Inc (NYSE: RMD) posted Q4 adjusted EPS of $1.60, up from $1.49 a year ago, missing the consensus of $1.67. 
Via Benzinga
12 Health Care Stocks Moving In Friday's Intraday Session
Via Benzinga
Looking Into ResMed's Recent Short Interest
Via Benzinga
Here's How Much $100 Invested In ResMed 20 Years Ago Would Be Worth Today
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
  On Friday, 73 companies reached new 52-week lows. 
Via Benzinga
ResMed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2023
From ResMed Inc.
Via GlobeNewswire
Peering Into ResMed's Recent Short Interest
Via Benzinga
$1000 Invested In This Stock 15 Years Ago Would Be Worth $11,000 Today
Via Benzinga
If You Invested $100 In This Stock 5 Years Ago, You Would Have $200 Today
Via Benzinga
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition. 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For August 1, 2023
Via Benzinga
Here's How Much You Would Have Made Owning ResMed Stock In The Last 10 Years
Via Benzinga
ResMed to Report Fourth Quarter Fiscal 2023 Earnings on August 3, 2023
From ResMed Inc.
Via GlobeNewswire
ResMed Acquires Somnoware, a Leader in Digital Sleep and Respiratory Care Diagnostics Software
From ResMed Inc.
Via GlobeNewswire
PAP Adherence Lowers ER Visits 24-36% in 1 Year for People with Sleep Apnea and Heart Failure: ResMed Studies Presented at SLEEP
From ResMed Inc.
Via GlobeNewswire
A Bullish Sign Appears On ResMed's Chart
Via Benzinga
ResMed Announces Participation in the Goldman Sachs 44th Annual Global Healthcare Conference
From ResMed Inc.
Via GlobeNewswire
3 World-Renowned Sleep Apnea Experts Present New Benefits of PAP Therapies at ATS 2023
From ResMed Inc.
Via GlobeNewswire
Benzinga's Top Ratings Upgrades, Downgrades For May 22, 2023
Via Benzinga
< Previous 1 2
...
7 8 9 10 11 12 13 14 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.